| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 03/03/2005 | WO2005019179A2 Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases |
| 03/03/2005 | CA2532020A1 6-(2,2,2-trifluoroethylamino)-7-chloro-2,3,4,5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist |
| 03/03/2005 | CA2529401A1 Processes for preparing 3-benzazepines |
| 03/02/2005 | EP1509504A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 03/02/2005 | EP1042279B1 Substituted beta-alanines |
| 03/02/2005 | CN1589153A Preventives/remedies for urinary disturbance |
| 03/02/2005 | CN1589145A αv整联蛋白受体拮抗剂 αv integrin receptor antagonists |
| 03/02/2005 | CN1191237C Substituted caprolactam carbonates and ethers and their use as anti-tumor agents |
| 02/24/2005 | WO2005016891A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585753A Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
| 02/23/2005 | CN1585752A 4, 4-difluoro-1, 2, 3, 4-tetrahydro-5H-1-benzazepine derivatives or salts thereof |
| 02/23/2005 | CN1585744A Process for the preparation of benazepril |
| 02/17/2005 | WO2005014578A1 Phenylsulfonyl compounds as antipsychotic agents |
| 02/17/2005 | WO2005014574A1 Substituted lactams and their use as anti-cancer agents |
| 02/17/2005 | WO2004002491A8 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 02/17/2005 | US20050038081 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide |
| 02/17/2005 | US20050038012 use in improvement of gastrointestinal blood flow, in treatment of hypertension and in treatment and prophylaxis of cardiac damages induced by adriamycin and comparable anti-cancer drugs |
| 02/17/2005 | CA2533335A1 Substituted lactams and their use as anti-cancer agents |
| 02/16/2005 | EP1506040A2 Selective inos inhibitors for the treatment of respiratory diseases and conditions |
| 02/16/2005 | EP1505972A2 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases |
| 02/16/2005 | CN1189456C Process for producing high purity caprolactam |
| 02/16/2005 | CN1189450C Semihydrogenation method for dinitriles |
| 02/16/2005 | CN1189247C Method for regenerating catalyst for cyclizing hydrolysis amionotrile into lactam |
| 02/10/2005 | WO2005012266A1 (thio) carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists |
| 02/10/2005 | WO2004110983A3 New benzamides as pparϒ modulators |
| 02/10/2005 | US20050030912 Use of hybrid (HW/DSP/MCU/SW) architectures for powerline OFDM communication field |
| 02/10/2005 | US20050029086 Mixture containing impurities, base; controlling alkalinity; purification |
| 02/09/2005 | EP1503989A1 Dopamine receptor modulators as antipsychotic agents |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/08/2005 | US6852713 Lactam derivatives and methods of their use |
| 02/03/2005 | WO2005009972A2 Process for preparation of benazepril |
| 02/03/2005 | US20050026956 Carbinols for the treatment of neuropathic dysfunction |
| 02/02/2005 | EP1501814A1 Semicarbazide derivatives for combating thromboembolic diseases |
| 02/02/2005 | EP1501516A1 A process for the preparation of benazepril hydrochloride |
| 02/02/2005 | EP1501467A2 Heterocyclo inhibitors of potassium channel function |
| 02/02/2005 | EP1044190B1 Synthesis of 11-aryl-5,6-dihydro-11h-dibenz(b,e)azepines |
| 02/02/2005 | CN1575282A Lactam compound |
| 02/02/2005 | CN1187361C Phosphoric-acid substituted benzo-aza-tropone-N-acetic acid derivative, preparing method and medicine thereof |
| 02/02/2005 | CN1187342C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 02/02/2005 | CN1187334C Preparation of hexanolactam |
| 02/02/2005 | CN1187333C Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
| 02/02/2005 | CN1187327C Method for production of N-alkenyl amides |
| 02/02/2005 | CN1187324C Process for the preparation of epsilon-caprolactam |
| 01/27/2005 | WO2005007630A2 Aryl fused azapolycyclic compounds |
| 01/27/2005 | US20050020616 Central nervous system and psychological disorders |
| 01/27/2005 | US20050020573 5HT2c receptor modulators |
| 01/27/2005 | US20050020505 Angiogenesis inhibitors; antitumor agents; anticancer agents; atherosclerosis; cardiovascular disorders; antiarthritic agents |
| 01/27/2005 | CA2533100A1 Aryl fused azapolycyclic compounds |
| 01/26/2005 | EP1500643A1 Benzamide derivatives |
| 01/26/2005 | CN1571772A Process for distilling alkaline caprolactam product at reduced pressure |
| 01/26/2005 | CN1569839A Meptazinol prodrug and its salts and its production method |
| 01/26/2005 | CN1569838A Meptazinol ortho-propionyloxy-cis-benzyl acrylate and its salts and their production method |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/26/2005 | CN1186321C Method for storing and transporting N-vinyl-epsilon- caprolactam |
| 01/25/2005 | US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/25/2005 | US6846813 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits |
| 01/20/2005 | WO2005005392A1 Azacyclic compounds as inhibitors of sensory neurone specific channels |
| 01/20/2005 | US20050011744 Process for recovering caprolactam from aqueous caprolactam product using situ prepared alkali amino caproate |
| 01/20/2005 | DE10330413A1 Caprolactam-blocked isocyanate with at least two blocked isocyanate groups and at least two sec. amino groups, used for production of coating materials, e.g. 1-component, water-based systems for coating car bodies |
| 01/19/2005 | EP1497270A1 Amide compounds and methods of using the same |
| 01/19/2005 | EP1337254B1 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence |
| 01/19/2005 | EP0777492B1 Combinatorial libraries of substrate-bound cyclic organic compounds |
| 01/19/2005 | CN1565720A Solid acid catalyzer for synthesizing caprolactam |
| 01/19/2005 | CN1185218C Process for synthesizing epsilon-hexanolactam |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/13/2005 | WO2005003096A1 Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases |
| 01/13/2005 | US20050009807 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
| 01/13/2005 | US20050009755 (74)(3S)-3-amino-1-(1-benzyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-4-yl)-5-methyl-2-heptanone for example; cysteine protease inhibitors; treating bone resorption diseases such as osteoporosis |
| 01/12/2005 | EP1496051A1 Method for preparing 6-aminomethyl-6,11-dihydro-5h-dibenz(b,e)azepine |
| 01/12/2005 | EP1495004A2 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor ligands |
| 01/12/2005 | EP1494998A2 Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| 01/12/2005 | EP1165532B1 Antibacterial agents |
| 01/06/2005 | WO2005000819A1 Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives |
| 01/06/2005 | US20050004360 Compounds and methods for modulation of estrogen receptors |
| 01/06/2005 | US20050004112 C-fms kinase inhibitors |
| 01/06/2005 | US20050004103 Vasopressin active material; antidiabetic agents; diuretics; bioavailability |
| 01/06/2005 | US20050004102 Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
| 01/06/2005 | CA2529513A1 Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives |
| 01/05/2005 | EP1492518A2 Tuberculosis treatment using pleuromutilin derivatives |
| 01/05/2005 | EP1124619B1 Process for purifying solid chemical products by dry-sweating |
| 01/04/2005 | US6838454 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 01/04/2005 | CA2124696C Vasopressin antagonist and oxytocin antagonist |
| 12/30/2004 | US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 12/30/2004 | US20040266754 Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-carboxamide and optically enriched mixtures thereof |
| 12/30/2004 | US20040266752 vasopressin receptor antagonists; useful as therapeutics in or prophylactics against conditions such as aggression, obsessive-compulsive disorders, hypertension, dysmenorrhea, hyponatremia, congestive heart failure/cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, etc. |
| 12/29/2004 | WO2004113297A2 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2004 | WO2004113288A1 Method for making caprolactam |
| 12/29/2004 | CN1557945A Preparation of lactams from aliphatic alpha , omega -dinitiles |
| 12/29/2004 | CN1181817C NF-KB inhibitors containing phenylmethyl benzoquinone as active ingredient |
| 12/29/2004 | CA2528538A1 Dual function compounds and uses thereof |
| 12/28/2004 | US6835830 Method for evaporating aminonitrile |
| 12/23/2004 | WO2004110986A1 Benzamide derivative or salt thereof |
| 12/23/2004 | WO2004110983A2 New benzamides as pparϒ modulators |
| 12/23/2004 | US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence |
| 12/23/2004 | US20040259857 Hypotensive agents; dysmenorrhea; antiischemic agents; liver cirrhosis; kidney diseases; liver disorders; strokes; cantral nervous system disorders |
| 12/23/2004 | CA2528231A1 New benzamides as ppar.gamma. modulators |
| 12/23/2004 | CA2526387A1 Benzamide derivative or salt thereof |
| 12/22/2004 | EP1487801A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo[d]azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders |